Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Santarus expects OTC Zegerid in 2010: The proton pump inhibitor's originator expects Merck/Schering-Plough to launch OTC Zegerid, should FDA approve it, in the first half of 2010. FDA's action date on the Zegerid switch application is set for December (1"The Tan Sheet" June 29, 2009, In Brief). In its Nov. 4 earnings release, San Diego-based Santarus raised its fiscal 2009 revenue guidance to $150 million from $145 million, but expects challenging quarters ahead due to changes in the PPI market, including this month's planned launch of Novartis' OTC Prevacid 24HR. Santarus increased product-related revenues 29.8 percent to $38.3 million in the third quarter. Rx Zegerid sales grew 12.1 percent to $31.5 million
You may also be interested in...
Nature's Products acquires Nutrition 21 businesses
Contract manufacturer and consumer health products packager Nature's Products acquires Nutrition 21's Iceland Health vitamin brand and its store-brand business for $3.2 million. Purchase, N.Y.-based Nutrition 21 signed a letter of intent in November, saying it would divest certain assets because the firm's revenues had suffered in the first quarter of 2010 (1"The Tan Sheet" Nov. 9, 2009). Nutrition 21 said it will retain its "profitable ingredients business and its patent portfolio." Nature's Products of Sunrise, Fla., noted Dec. 30 that Iceland Health is "a leading brand in the direct response and mass market channels" focused on omega-3s and joint-care and will complement the firm's diversification strategy. The acquisition also will provide synergies in materials and operations areas, and will streamline the supply chain. Nature's Products plans to enhance its nutritional product offerings, strengthen and develop marketing campaigns and secure new leadership
Nature's Products acquires Nutrition 21 businesses
Contract manufacturer and consumer health products packager Nature's Products acquires Nutrition 21's Iceland Health vitamin brand and its store-brand business for $3.2 million. Purchase, N.Y.-based Nutrition 21 signed a letter of intent in November, saying it would divest certain assets because the firm's revenues had suffered in the first quarter of 2010 (1"The Tan Sheet" Nov. 9, 2009). Nutrition 21 said it will retain its "profitable ingredients business and its patent portfolio." Nature's Products of Sunrise, Fla., noted Dec. 30 that Iceland Health is "a leading brand in the direct response and mass market channels" focused on omega-3s and joint-care and will complement the firm's diversification strategy. The acquisition also will provide synergies in materials and operations areas, and will streamline the supply chain. Nature's Products plans to enhance its nutritional product offerings, strengthen and develop marketing campaigns and secure new leadership
Nature's Products acquires Nutrition 21 businesses
Contract manufacturer and consumer health products packager Nature's Products acquires Nutrition 21's Iceland Health vitamin brand and its store-brand business for $3.2 million. Purchase, N.Y.-based Nutrition 21 signed a letter of intent in November, saying it would divest certain assets because the firm's revenues had suffered in the first quarter of 2010 (1"The Tan Sheet" Nov. 9, 2009). Nutrition 21 said it will retain its "profitable ingredients business and its patent portfolio." Nature's Products of Sunrise, Fla., noted Dec. 30 that Iceland Health is "a leading brand in the direct response and mass market channels" focused on omega-3s and joint-care and will complement the firm's diversification strategy. The acquisition also will provide synergies in materials and operations areas, and will streamline the supply chain. Nature's Products plans to enhance its nutritional product offerings, strengthen and develop marketing campaigns and secure new leadership